BOSTON BASKIN CANCER FOUNDATION INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

JASON M LITTLE

Phone

9012273627

Tax Period

2019-10-01 to 2020-09-02

Mission

BOSTON BASKIN CANCER FOUNDATION, INC.'S MISSION IS TO PROVIDE COMPREHENSIVE HIGH-QUALITY MEDICAL CARE TO CANCER PATIENTS IN THE COMMUNITIES IT SERVES.

Program Service Accomplishments

Program 1

Expenses: $0 Revenue: $0

BOSTON BASKIN CANCER FOUNDATION, INC. WAS A MULTISPECIALTY ONCOLOGY PRACTICE WHICH TREATED A WIDE VARIETY OF COMPLEX CANCER CASES IN THE MID-SOUTH. BOSTON BASKIN CANCER FOUNDATION, INC. CEASED...

BOSTON BASKIN CANCER FOUNDATION, INC. WAS A MULTISPECIALTY ONCOLOGY PRACTICE WHICH TREATED A WIDE VARIETY OF COMPLEX CANCER CASES IN THE MID-SOUTH. BOSTON BASKIN CANCER FOUNDATION, INC. CEASED CONDUCTING BUSINESS AS OF SEPTEMBER 23, 2016. ALL REMAINING ASSETS AND LIABILITIES HAVE BEEN COLLECTED AND THIS ENTITY WAS LEGALLY DISSOLVED ON SEPTEMBER 2, 2020.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $0

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $0

TOTAL EXPENSES $0

Year-over-Year Comparison

	2019	2018	Change
Revenue	N/A	$21,345	-1.0%
Expenses	N/A	$14,791	-1.0%
Net Income	N/A	$6,554	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,411,110

Total Directors

$3,329,132

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PAUL D DEPRIEST MD	DIRECTOR	0.04	Director	$0	$66,047	$1,331,310
MARK E SWANSON MD	DIRECTOR/CEO	0.04	Officer Director	$0	$19,113	$1,199,111
GREGORY M DUCKETT	SECRETARY/DIRECTOR	0.04	Officer Director	$0	$69,972	$798,711
KIMBERLY O YOUNG	CFO (THRU 12/19)	0.04	Officer	$0	$26,435	$251,252
ANDREW JETER	CFO (AS OF 12/19)	0.04	Officer	$0	$19,282	$162,036

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	No data	No data	No data	No data
2019	$21,345	$14,791	No data	$6,554
2018	$142,829	$18,566	$796,937	$124,263